Your browser doesn't support javascript.
loading
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.
Zhao, Joseph J; Yap, Dominic Wei Ting; Chan, Yiong Huak; Tan, Benjamin Kye Jyn; Teo, Chong Boon; Syn, Nicholas L; Smyth, Elizabeth C; Soon, Yu Yang; Sundar, Raghav.
Afiliação
  • Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Yap DWT; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Chan YH; Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Tan BKJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Teo CB; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Syn NL; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Smyth EC; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Soon YY; Department of Radiation Oncology, National University Cancer Institute, Singapore.
  • Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
J Clin Oncol ; 40(4): 392-402, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34860570
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Estados Unidos